The network of procedures and establishments involved in the creation, production, delivery, and storage of cellular and gene-based treatments is known as the "Cell and Gene Supply Chain." The procurement of raw ingredients, gene or cell manipulation, quality control, transportation, and patient administration are only a few of the phases that this intricate system entails. It is imperative to maintain the integrity and safety of these cutting-edge therapies at every stage of the supply chain to ensure that patients receive consistent, dependable, and efficient care.